Лобно-височная деменция в психиатрической практике: диагностические и терапевтические аспекты
https://doi.org/10.31363/2313-7053-2018-2-109-115
Аннотация
Об авторе
Игорь Владимирович Колыхалов
ФГБНУ «Научный цент психического здоровья», Москва
Россия
д.м.н., главный научный сотрудник отдела гериатрической психиатрии
Россия
д.м.н., главный научный сотрудник отдела гериатрической психиатрии
Список литературы
1. Михайлова Н.М., Гаврилова С.И. Альцгеймеровский центр — инновационная модель амбулаторной помощи пожилым больным с когнитивными расстройствами и деменцией. — Психиатрия. — 2015. — №3. — С.42- 51.
2. Руководство по гериатрической психиатрии. 2-е издание, переработанное и дополненное. Под ред. С.И. Гаврилова. — М.: Пульс. — 2014. — 384с.
3. Bowen D.M., Procter A.W., Mann D.M., Snowden J.S., Esiri M.M., Neary D., Francis P.T. Imbalance of a serotonergic system in frontotemporal dementia: implication for pharmacotherapy. Psychopharmacology (Berl). — 2008. — V.196. — P.603-610.
4. Boxer A.L., Knopman D.S., Kaufer D.I., Grossman M., Onyike C., Graf-Radford N., Mendez M., Kerwin D., Lerner A., Wu C.K., Koestler M., Shapira J., Sullivan K., Klepac K., Lipowski K., Ullah J., Fields S., Kramer J.H., Merrilees J., Neuhaus J., Mesulam M.M., Miller B.L. Memantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double-blind, placebo-controlled trial. — Lancet Neurol. — 2013. — V.12. — P.149-156.
5. Boxer A.L., Lipton A.M., Womack K., Merrilees J., Neuhaus J., Pavlic D., Gandhi A., Red D., MartinCook K., Svetlik D., Miller B.L. An open-label study of memantine treatment in 3 subtypes of frontotemporal lobar degeneration. — Alzheimer Dis Assoc Disord. — 2009. — V.23. — P.211-217.
6. Bozeat S., Gregory C.A., Ralph M.A., Hodges J.R. Which neuropsychiatric and behavioral features distinguish frontal and temporal variants of frontotemporal dementia from Alzheimer’s disease? — J Neurol Neurosurg Psychiatry. — 2000. — V.69. — P.178–186.
7. Chow T.W., Mendez M.F. Goals in symptomatic pharmacologic management of frontotemporal lobar degeneration. — Am J Alzheimers Dis Other Demen. — 2002. — V.17. — P.267-272.
8. Fellgiebel A., Müller M.J., Hiemke C., Bartenstein P., Schreckenberger M.. Clinical improvement in a case of frontotemporal dementia under aripiprazole treatment corresponds to partial recovery of disturbed frontal glucose metabolism. — World J Biol Psychiatry. — 2007. — V.8. — P.123-126.
9. Gorno-Tempini ML, Hillis AE, Weintraub S, et al. Classifcation of primary progressive aphasia and its variants.—Neurology.—2011.—V.76.—P.1006-1014.
10. Herrmann N, Black SE, Chow T, Cappell J, TangWai DF, Lanctôt KL Serotonergic function and treatment of behavioral and psychological symptoms of frontotemporal dementia. — Am J Geriatr Psychiatry. — 2012. — V.20. — P.789-797.
11. Ikeda M., Shigenobu K., Fukuhara R., Hokoishi K., Maki N., Nebu A., Komori K., Tanabe H. Efcacy of fluvoxamine as a treatment for behavioral symptoms in frontotemporal lobar degeneration patients. — Dement Geriatr Cogn Disord. — 2004 — V.17 — P.117-121.
12. Lanctôt K.L., Herrmann N., Ganjavi H., Black S.E., Rusjan P.M., Houle S., Wilson A.A. Serotonin-1A receptors in frontotemporal dementia compared with controls. — Psychiatry Res. — 2007. — V.156. — P.247-250.
13. Levy M.L., Miller B.L., Cummings J.L., Fairbanks L.A., Craig A. Alzheimer disease and frontotemporal dementias: behavioral distinctions. — Arch Neurol. — 1996 — V.53. — P.687-690.
14. Li P., Quan W., Zhou Y.Y., Wang Y., Zhang H.H., Liu S. Efcacy of memantine on neuropsychiatric symptoms associated with the severity of behavioral variant frontotemporal dementia: A six-month, open-label, self-controlled clinical trial. — Exp. Ter. Med. — 2016. — V.12. — P.492-498.
15. Liu W., Miller B.L., Kramer J.H., et al. Behavioral disorders in the frontal and temporal variants of frontotemporal dementia. — Neurology. — 2004. — V.62. — P.742–748.
16. Lopez O.L., Becker J.T., Reynolds C.F., et al. Symptoms of depression and psychosis in Alzheimer’s disease and frontotempora dementia. — Neuropsychiatry Neuropsychol Behav Neurol. –1996. — V.9. — P.154–161.
17. Mendez M.F. Frontotemporal dementia: therapeutic interventions. Front Neurol Neurosci. — 2009. — V.24. — P.168-178.
18. Mendez M.F., Perryman K.M., Miller B.L., Cummings J.L. Behavioral differences between frontotemporal dementia and Alzheimer’s disease: a comparison on the BEHAV-AD rating scale. — Int Psychogeriatr. — 1998. — V.10. — P.155–162.
19. Moretti R., Torre P., Antonello R.M., et al. Olanzapine as a treatment of neuropsychiatric disorders of Alzheimer’s disease and other dementias: a 24-month follow-up of 68 patients. — Am J Alzheimers Dis Other Demen. — 2003. — V.18. — P.205-214.
20. Mourik J.C., Rosso S.M., Niermeijer M.F., Duivenvoorden H.J., Van Swieten J.C., Tibben A. Frontotemporal dementia: behavioral symptoms and caregiver distress. — Dement Geriatr Cogn Disord. — 2004. — V.18. — P.299–306.
21. Peters F., Perani D., Herholz K., Holthoff V., Beuthien-Baumann B., Sorbi S, Pupi A., Degueldre C., Lemaire C., Collette F., Salmon E. Orbitofrontal dysfunction related to both apathy and disinhibition in frontotemporal dementia. — Dement Geriatr Cogn Disord. — 2006. — V.21. — P.373–379.
22. Pfeffer A., Luczywek E., Golebiowski M., Czyzewski K., Barcikowska M. Frontotemporal dementia: an attempt at clinical characteristics. — Dement Geriatr Cogn Disord. — 1999. — V.10. — P.217–220.
23. Prodan C.I., Monnot M., Ross E.D. Behavioural abnormalities associated with rapid deterioration of language functions in semantic dementia respond to sertraline. — J Neurol Neurosurg Psychiatry. — 2009. — V.80. — P.1416-1417.
24. Rascovsky K., Hodges J.R., Knopman D., et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. — Brain. — 2011. — V.134. — P.2456-2477.
25. Ratnavalli E., Brayne C., Dawson K, Hodges J.R. Te prevalence of fronto-temporal dementia. — Neurology. — 2002. — V. 58. — P.1615-1621.
26. Shinagawa S., Ikeda M., Fukuhara R., Tanabe H. Initial symptoms in frontotemporal dementia and semantic dementia compared with Alzheimer’s disease. — Dement Geriatr Cogn Disord. — 2006. — V.21. — P.74–80.
27. Snowden J.S., Bathgate D., Varma A., et al: Distinct behavioural profles in frontotemporal dementia and semantic dementia. — J Neurol Neurosurg Psychiatry. — 2001. — V.70. — P.323-332.
28. Swanberg M.M. Memantine for behavioral disturbances in frontotemporal dementia: a case series. — Alzheimer Dis Assoc Disord. — 2007 — V.21 — P.164-166.
29. Tsai R.M., Boxer A.L. Terapy and clinical trials in frontotemporal dementia: past, present, and future.—J Neurochem.—2016.—V.138.—P.211–221.
30. Vercelletto M., Boutoleau-Bretonnière C., Volteau C., Puel M., Auriacombe S., Sarazin M., Michel B.F., Couratier P., Tomas-Antérion C., Verpillat P., Gabelle A., Golfer V., Cerato E., Lacomblez L. French research network on Frontotemporal dementiaMemantine in behavioral variant frontotemporal dementia: negative results. — J Alzheimers Dis. — 2011. — V.23. — P.749-59.
31. Vieira R.T., Caixeta L., Machado S. Silva A.C., Nardi A.E., Arias-Carrión O., Carta M.G. Epidemiology of early-onset dementia: review of the literature. — Clin. Pract. Epidemiol. Ment. Health. — 2013. — V.9 — P.88-95.
32. WHO. Dementia fact sheet. — 2015. http://www.who.int/mediacentre/factsheets/fs362/en/
33. Woolley J.D., Khan B.K., Murthy N.K., Miller B.L., Rankin K.P. Te diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease. — J Clin Psychiatry. — 2011. — V.72. — P.126-133.
34. Yang Y., Schmitt H.P. Frontotemporal dementia: evidence for impairment of ascending serotoninergic but not noradrenergic innervation. Immunocytochemical and quantitative study using a graph method. — Acta Neuropathol. — 2001. — V.101. — P. 256-270.
Рецензия
Для цитирования:
Колыхалов И.В. Лобно-височная деменция в психиатрической практике: диагностические и терапевтические аспекты. Обозрение психиатрии и медицинской психологии имени В.М.Бехтерева. 2018;(2):109-115. https://doi.org/10.31363/2313-7053-2018-2-109-115
For citation:
Kolykhalov I.V. Frontotemporal dementia in psychiatric practice: diagnostic and therapeutic aspects. V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY. 2018;(2):109-115. (In Russ.) https://doi.org/10.31363/2313-7053-2018-2-109-115
Просмотров: 15319
Послать статью по эл. почте 